VARIAN MEDICAL SYSTEMS INC
Healthcare · Electromedical & Electrotherapeutic Apparatus · DE · SEC filings ↗ · Compare ⊕
Financials
SEC XBRL · annual| FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | |
|---|---|---|---|---|---|---|
| Revenue | $3.17B | $3.23B | $2.92B | $663.2M | $2.59B | $2.49B |
| Operating income | $323.2M | $386.2M | $441.6M | $300.2M | $426.8M | $395.7M |
| Net income | $88.2M | $88.6M | $73.2M | $56.3M | $399.3M | $411.5M |
| Total assets | $4.46B | $4.10B | $3.25B | $3.29B | $3.81B | $3.58B |
| Total liabilities | $2.38B | $2.32B | $1.66B | $1.77B | $2.06B | $1.85B |
| Equity | $2.08B | $1.77B | $1.58B | $1.52B | $1.74B | $1.71B |
| EPS (diluted) | $0.96 | $0.96 | $0.79 | $0.60 | $4.16 | $4.09 |
| Shares out. | 91.4M | 90.9M | 91.1M | 91.6M | 93.4M | 96.9M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2020- Operating margin
- 10.2%
- Net margin
- 2.8%
- Return on equity
- 4.2%
- Return on assets
- 2.0%
- Return on capital (ROCE)
- 12.4%
- Liabilities / assets
- 53.3%
- Debt / equity
- 1.15×
- Book value / share
- $22.72
- Revenue growth (YoY)
- −1.8%
- Net income growth (YoY)
- −0.5%
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2020- Altman Z″ (distress)
- 3.33safe
- Accruals / assets
- −8.9%clean
- Beneish M-Score
- -2.93normal
- Piotroski F-Score
- 5/9mixed
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast. What these scores mean →
Signs
● 1 warning● 4 good- Revenue declined year-over-year
- Operating margin is positive
- Positive operating cash flow
- Clean earnings (low accruals)
- Altman Z″ in the safe zone
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Insider transactions
SEC Form 4 · most recent| Insider | Date | Type | Shares | Price |
|---|---|---|---|---|
| Balser Jeffrey R.Director | Apr 15, 2021 | D | 2,824 | — |
| Butel Jean LucDirector | Apr 15, 2021 | D | 4,048 | — |
| Dugan Regina EDirector | Apr 15, 2021 | D | 12,396 | — |
| Eckert R AndrewDirector | Dec 2, 2020 | Gift | 277 | $0.00 |
| Bruner JudyDirector | Apr 15, 2021 | D | 6,779 | — |
| Illingworth David JDirector | Apr 15, 2021 | D | 15,369 | — |
| Wilson Dow ROfficer — President and CEO | Nov 5, 2020 | Gift | 46,700 | $0.00 |
| Febbo Phillip G.Director | Apr 15, 2021 | D | 1,699 | — |
| Hutchinson Michael DamonOfficer — SVP,Chief Legal Officer, Secy | Apr 15, 2021 | D | 5,589 | — |
| Momsen MagnusOfficer — SVP, CAO, Corporate Controller | Apr 15, 2021 | D | 724 | — |
| Kennedy Kolleen TOfficer — Pres. Proton Solutions, CGO | Apr 15, 2021 | D | 29,249 | — |
| O'Reilly KevinOfficer — SVP, President of Oncology Sys | Apr 15, 2021 | D | 1,556 | — |
Headline trade per Form 4 (officers, directors, 10%+ owners). Buy/sell read from the filing's structured data — blank where a field isn't cleanly tagged.
Material events
SEC Form 8-K · most recent- Terminated a material agreement · Completed an acquisition or disposition · Delisting / listing-standard notice · Modified shareholder rights · Change in control · Director / officer change · Amended charter or bylawsApr 15, 2021
- Director / officer changeApr 8, 2021
- Director / officer changeMar 8, 2021
- Director / officer change · Regulation FD disclosureMar 2, 2021
- Results of operationsJan 26, 2021
- Director / officer changeNov 27, 2020
- Other material eventNov 24, 2020
- Results of operationsOct 27, 2020
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- 15-12BApr 26, 2021
- 4PRIMARY DOCUMENTApr 16, 2021
- 4PRIMARY DOCUMENTApr 16, 2021
- 4PRIMARY DOCUMENTApr 16, 2021
- 4PRIMARY DOCUMENTApr 16, 2021
- 4PRIMARY DOCUMENTApr 16, 2021
- 4PRIMARY DOCUMENTApr 16, 2021
- 4PRIMARY DOCUMENTApr 16, 2021
- 4PRIMARY DOCUMENTApr 16, 2021
- 4PRIMARY DOCUMENTApr 16, 2021
- 4PRIMARY DOCUMENTApr 16, 2021
- 4PRIMARY DOCUMENTApr 16, 2021
- 4PRIMARY DOCUMENTApr 16, 2021
- 4PRIMARY DOCUMENTApr 16, 2021
- 4PRIMARY DOCUMENTApr 16, 2021
Corporate family
Spin-offs from VARIAN MEDICAL SYSTEMS INC (1)
- Varex Imaging CorpVREXcompletedJan 27, 2017details
From the spin-off filings we track. Follow a company to walk its own history.
Event-driven situations (2)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.